LOS ANGELES–(BUSINESS WIRE)–City of Hope will present new research on cellular therapies and targeted treatments for blood cancers at the 2026 ASH Annual Meeting and Exposition.
Tag: Business Wire
LOS ANGELES–(BUSINESS WIRE)–City of Hope will present new research on cellular therapies and targeted treatments for blood cancers at the 2026 ASH Annual Meeting and Exposition.
NEW YORK & NEW ORLEANS–(BUSINESS WIRE)–Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Option Care Health, Inc. (NasdaqGS: OPCH) to CD&R, McKesson Corporation. Under the terms of the proposed transaction, shareholders of Option Care will receive $32.05 in cash for each share of Option Care that they own. KSF is seeking to determine whether this consideration and the process that l
NEW YORK & NEW ORLEANS–(BUSINESS WIRE)–Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Option Care Health, Inc. (NasdaqGS: OPCH) to CD&R, McKesson Corporation. Under the terms of the proposed transaction, shareholders of Option Care will receive $32.05 in cash for each share of Option Care that they own. KSF is seeking to determine whether this consideration and the process that l
NEW ORLEANS–(BUSINESS WIRE)–Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Fulcrum Therapeutics, Inc. (NasdaqGM: FULC) and Slate Medicines, Inc. Upon closing of the proposed transaction, Fulcrum shareholders are expected to own 5.0% of the combined company. KSF is seeking to determine whether the merger and the process that led to it are adequate, or whether the merger is fair to F
NEW ORLEANS–(BUSINESS WIRE)–Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Fulcrum Therapeutics, Inc. (NasdaqGM: FULC) and Slate Medicines, Inc. Upon closing of the proposed transaction, Fulcrum shareholders are expected to own 5.0% of the combined company. KSF is seeking to determine whether the merger and the process that led to it are adequate, or whether the merger is fair to F
NASHVILLE, Tenn.–(BUSINESS WIRE)—- $IIIV–i3 Verticals, Inc. (Nasdaq: IIIV) (“i3 Verticals” or the “Company”) today reported its financial results for the fiscal fourth quarter and year ended September 30, 2026. Fourth Fiscal Quarter 2026 Highlights from continuing operations (all comparisons are to the fourth fiscal quarter of 2025): Revenues: Revenue from continuing operations was $55.4 million, an increase of 1.0%. Annualized Recurring Revenue (“ARR”) from continuing operations was $177.0 million,
NASHVILLE, Tenn.–(BUSINESS WIRE)—- $IIIV–i3 Verticals, Inc. (Nasdaq: IIIV) (“i3 Verticals” or the “Company”) today reported its financial results for the fiscal fourth quarter and year ended September 30, 2026. Fourth Fiscal Quarter 2026 Highlights from continuing operations (all comparisons are to the fourth fiscal quarter of 2025): Revenues: Revenue from continuing operations was $55.4 million, an increase of 1.0%. Annualized Recurring Revenue (“ARR”) from continuing operations was $177.0 million,
OLDWICK, N.J.–(BUSINESS WIRE)– #insurance–AM Best has upgraded the Financial Strength Rating to A- (Excellent) from B++ (Good) and the Long-Term Issuer Credit Ratings to “a-” (Excellent) from “bbb+” (Good) of Kansas Medical Mutual Insurance Company and its subsidiary, KAMMCO Casualty Company, Inc. These companies are domiciled in Topeka, KS and collectively referred to as Kansas Medical Mutual Group or the group. The outlook of these Credit Ratings (ratings) has been revised to stable from positive.The ra
BRENTWOOD, Tenn.–(BUSINESS WIRE)–Please replace the release with the following corrected version due to multiple revisions. The updated release reads: ARDENT HEALTH ANNOUNCES PROPOSED SECONDARY OFFERING OF COMMON STOCK AND CONCURRENT SHARE REPURCHASE Ardent Health, Inc. (NYSE: ARDT) (“Ardent Health” or the “Company”) today announced the commencement of a proposed secondary public offering (the “Offering”) of 8,000,000 shares of its common stock, consisting of 7,136,719 shares of its common st
